Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which could see a doubling of overall industry capacity over the next few months.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/2OMP6Bg
0 Comments